{"name":"Pro Top & Mediking Company Limited","slug":"pro-top-mediking-company-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"MMC in Trabeculectomy","genericName":"MMC in Trabeculectomy","slug":"mmc-in-trabeculectomy","indication":"Adjunctive use in trabeculectomy for primary open-angle glaucoma","status":"phase_3"},{"name":"MMC in glaucoma filtering surgery","genericName":"MMC in glaucoma filtering surgery","slug":"mmc-in-glaucoma-filtering-surgery","indication":"Glaucoma filtering surgery (adjunctive intraoperative use to reduce postoperative scarring)","status":"phase_3"},{"name":"Trabeculectomy with MMC","genericName":"Trabeculectomy with MMC","slug":"trabeculectomy-with-mmc","indication":"Open-angle glaucoma refractory to medical therapy","status":"marketed"}]}],"pipeline":[{"name":"MMC in Trabeculectomy","genericName":"MMC in Trabeculectomy","slug":"mmc-in-trabeculectomy","phase":"phase_3","mechanism":"Mitomycin C (MMC) is an alkylating agent that inhibits fibroblast proliferation and collagen synthesis to prevent scarring during trabeculectomy surgery.","indications":["Adjunctive use in trabeculectomy for primary open-angle glaucoma","Adjunctive use in trabeculectomy for secondary glaucomas"],"catalyst":""},{"name":"MMC in glaucoma filtering surgery","genericName":"MMC in glaucoma filtering surgery","slug":"mmc-in-glaucoma-filtering-surgery","phase":"phase_3","mechanism":"MMC (mitomycin C) inhibits fibroblast proliferation and collagen synthesis to prevent scarring after glaucoma filtering surgery.","indications":["Glaucoma filtering surgery (adjunctive intraoperative use to reduce postoperative scarring)"],"catalyst":""},{"name":"Trabeculectomy with MMC","genericName":"Trabeculectomy with MMC","slug":"trabeculectomy-with-mmc","phase":"marketed","mechanism":"Trabeculectomy with MMC is a surgical procedure that creates a drainage pathway in the eye while using mitomycin C to prevent scar tissue formation and maintain long-term filtration.","indications":["Open-angle glaucoma refractory to medical therapy","Angle-closure glaucoma","Secondary glaucomas"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}